» Articles » PMID: 12716461

Hypermethylation of the TSLC1 Gene Promoter in Primary Gastric Cancers and Gastric Cancer Cell Lines

Overview
Specialty Oncology
Date 2003 Apr 30
PMID 12716461
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The TSLC1 (tumor suppressor in lung cancer-1) gene is a novel tumor suppressor gene on chromosomal region 11q23.2, and is frequently inactivated by concordant promoter hypermethylation and loss of heterozygosity (LOH) in non-small cell lung cancer (NSCLC). Because LOH on 11q has also been observed frequently in other human neoplasms including gastric cancer, we investigated the promoter methylation status of TSLC1 in 10 gastric cancer cell lines and 97 primary gastric cancers, as well as the corresponding non-cancerous gastric tissues, by bisulfite-SSCP analysis followed by direct sequencing. Allelic status of the TSLC1 gene was also investigated in these cell lines and primary gastric cancers. The TSLC1 promoter was methylated in two gastric cancer cell lines, KATO-III and ECC10, and in 15 out of 97 (16%) primary gastric cancers. It was not methylated in non-cancerous gastric tissues, suggesting that this hypermethylation is a cancer-specific alteration. KATO-III and ECC10 cells retained two alleles of TSLC1, both of which showed hypermethylation, associated with complete loss of gene expression. Most of the primary gastric cancers with promoter methylation also retained heterozygosity at the TSLC1 locus on 11q23.2. These data indicate that bi-allelic hypermethylation of the TSLC1 promoter and resulting gene silencing occur in a subset of primary gastric cancers.

Citing Articles

Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1.

Engelmann C, Schuhmachers P, Zdimerova H, Virdi S, Hauri-Hohl M, Pachlopnik Schmid J Cell Death Dis. 2022; 13(10):892.

PMID: 36270981 PMC: 9587222. DOI: 10.1038/s41419-022-05337-z.


promotes adhesion to vascular endothelial cells and transendothelial migration in cultured GIST cells.

Yuan J, Kihara T, Kimura N, Yamasaki T, Yoshida M, Isozaki K Oncol Lett. 2022; 23(3):86.

PMID: 35126728 PMC: 8805184. DOI: 10.3892/ol.2022.13206.


Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer.

Li H, Gao J, Zhang S Front Cell Dev Biol. 2021; 9:714298.

PMID: 34395444 PMC: 8361327. DOI: 10.3389/fcell.2021.714298.


Differential Expression of in Gastrointestinal Stromal Tumors of Different Sites and with Different Gene Abnormalities.

Yuan J, Kihara T, Kimura N, Hashikura Y, Ohkouchi M, Isozaki K Pathol Oncol Res. 2021; 27:602008.

PMID: 34257559 PMC: 8262239. DOI: 10.3389/pore.2021.602008.


Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy.

Kanke Y, Saito M, Abe N, Saito K, Goto A, Ohtake T Oncol Lett. 2019; 17(1):921-926.

PMID: 30655848 PMC: 6313031. DOI: 10.3892/ol.2018.9727.


References
1.
Gomyo H, Arai Y, Tanigami A, Murakami Y, Hattori M, Hosoda F . A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2. Genomics. 1999; 62(2):139-46. DOI: 10.1006/geno.1999.6001. View

2.
Negrini M, Rasio D, Hampton G, Sabbioni S, Rattan S, Carter S . Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res. 1995; 55(14):3003-7. View

3.
Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y . Quantitative DNA methylation analysis by fluorescent polymerase chain reaction single-strand conformation polymorphism using an automated DNA sequencer. Electrophoresis. 2000; 21(5):904-8. DOI: 10.1002/(SICI)1522-2683(20000301)21:5<904::AID-ELPS904>3.0.CO;2-4. View

4.
Sakata K, Tamura G, Endoh Y, Ohmura K, Ogata S, Motoyama T . Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability. Br J Cancer. 2002; 86(4):564-7. PMC: 2375269. DOI: 10.1038/sj.bjc.6600076. View

5.
Carter S, Negrini M, Baffa R, Gillum D, Rosenberg A, Schwartz G . Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res. 1994; 54(23):6270-4. View